LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 88.76 | 17.25 | 83 | 6047 | 0.0137 | 0.2042 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 88.76 | 17.25 | 9128 | 6047 | 1.5093 | 1.0998 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 88.76 | 17.25 | 2 | 6047 | 0.0003 | -0.2250 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 88.76 | 17.25 | 10265 | 6047 | 1.6973 | 1.1292 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 90.74 | 17.25 | 64 | 6109 | 0.0105 | 0.1674 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 90.74 | 17.25 | 9147 | 6109 | 1.4972 | 1.0976 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 90.74 | 17.25 | 10587 | 6109 | 1.7329 | 1.1342 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.71 | 17.25 | 38 | 6184 | 0.0061 | 0.0975 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.71 | 17.25 | 9217 | 6184 | 1.4904 | 1.0963 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.71 | 17.25 | 10833 | 6184 | 1.7517 | 1.1366 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 17.25 | 17 | 6239 | 0.0027 | -0.0017 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 17.25 | 9223 | 6239 | 1.4782 | 1.0941 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 17.25 | 11014 | 6239 | 1.7653 | 1.1383 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 3.06 | 17.25 | 2 | 143 | 0.0140 | -0.5062 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 3.06 | 17.25 | 326 | 143 | 2.2763 | 1.6183 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 3.06 | 17.25 | 440 | 143 | 3.0723 | 1.8885 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 5.03 | 17.25 | 566 | 273 | 2.0706 | 1.4007 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 5.03 | 17.25 | 845 | 273 | 3.0912 | 1.6546 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.01 | 17.25 | 2 | 389 | 0.0051 | -0.3807 | MN20160310_N02 | E17 |